Leadership of the Department of Interventional Cardiology.
Research Institute. Hospital Cardiológica Aguascalientes, Aguascalientes, Mexico.
Arch Cardiol Mex. 2022;92(3):377-389. doi: 10.24875/ACM.21000301.
Hypertrophic cardiomyopathy (HCM) is a clinical condition, but its name has been subjected to frequent changes over the years, largely because of its morphological and functional heterogeneity, which leads the clinician who is focused on its study to have difficulty in understanding how to diagnose it and when and how to treat it. Regarding its name, it has been called in more than 75 different ways, and it has being classified with difficulty through echocardiography for more than 40 years. Today, it is necessary to understand that the diverse phenotypic behavior, as well as the evolutionary stages of the disease, must be approached in a practical and effective way, so that it easier to understand its clinical behavior and prognosis, as well as the therapeutic needs in each particular case. We review the aspects related to the name of the condition and propose a new classification that could provide the clinical and surgical cardiologist a better understanding of HCM in its various morphological and functional aspects.
肥厚型心肌病(HCM)是一种临床病症,但多年来其名称一直频繁变化,主要是因为其形态学和功能的异质性,这使得专注于其研究的临床医生难以理解如何诊断以及何时以及如何治疗它。关于它的名称,已经有超过 75 种不同的叫法,并且通过超声心动图对其进行分类已经有 40 多年的历史了。如今,我们必须认识到,疾病的多种表型行为以及疾病的发展阶段必须以一种实用和有效的方式来处理,以便更容易理解其临床行为和预后,以及在每种特殊情况下的治疗需求。我们回顾了与该病症名称相关的方面,并提出了一种新的分类方法,以便临床和心脏外科医生更好地理解 HCM 在其各种形态和功能方面的表现。